Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
PaperCitations, authors & open-access status
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 692 citations, 2021 year and green oa status.
692
Citations
2021
Year
green
OA Status